课题基金 / 基金详情

Apoptosis induces of a multi-drug resistant oral cancer cells by Tax01, Alkaroid derived ICHI

Apoptosis induces of a multi-drug resistant oral cancer cells by Tax01, Alkaroid derived ICHI
生物碱衍生的 ICHI Tax01 诱导多重耐药口腔癌细胞凋亡
批准号:
12671940
负责人:
TANAKA Yoshiharu
金额:
$1.73万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

TANAKA Yoshiharu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
[purpose]Medical treatment by combined use of the conventional chemotheraoy, radiotherapy, a surgery treatment, etc. has been performed to the squampus cell carcinoma which has the large majority of many malignant tumor. However, you should not carry out satisfactory of the medical treatment results. Moreover, existence of the cancer cell which shows reresitance is indicated to oral domain squamous cell carcinoma by the chemotherapeutic drug used tor high frequency, and it is said that the malignant tumor which shows resistance to one chemotherapeutic drug has the so-called cross resistance ability which shows resistance to other chemotherapeutic drugs.Recently, Taxol was found out as a new anti-neoplasm agent. Taxol is the alkaloid half-compounded from the department medicinal herb of ICHII, and is a different mechanism foreword from the conventional antineoplastic drug. In this study, comparison of Taxol's anti-neoplasm effect of multi drug resistance of the oral cancer cells establi … More shed by our laboratory in serum-free culture. Moreover, the resistance mechanism of a multi drug-resistant cancer can is reported.[result and conclusion]--Taxol did not show cross resistance to NA-CDDP cells and NA-ADM cells established by our laboratory. A possibility that Taxol expressed an effect was suggested also to the case which shows resistance to CDDP and ADM by which the present clinical application is carried out. Moreover, the amount of expression of MRP-2/cMOAT in NA-CDDP cells is the amount of expression of the amount of about 4 times as compared with NA cells, and it was suggested that MRP-2/cMOAT is participating in CDDP resistance significantly. On the other hand, since there was about 12-time amount of expression of MRP-3 gene of NA-CDDP cells as compared with NA cells, the rather than thing which the transportation-cell outside ability of CDDP through MRP-3 is going up was suggested through MRP-2/cMOAT. In conclusion, it was thought that Taxol became an effective cure to a multi-drug resistance oral cancer. Moreover, it was possible by solving the resistance mechanism of a multi drug-resistant cancer cell to contribute to diagnosis of medicine susceptibility. Less
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
田中良治: "Molecular diagnosis of human salivary gland tumors by differential expression of fibroblast growth factor genes."Tissue Culture Res, Commun.. 16. 207-212 (1997)
Ryoji Tanaka:“通过成纤维细胞生长因子基因的差异表达对人类唾液腺肿瘤进行分子诊断。”Tissue Culture Res,Commun.. 16. 207-212 (1997)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
田中良治: "Molecular Diagnosis and Gene Therapy of Salivary Gland Tumors"Int.J.Oral Maxillofac, Surg.. 26. 262 (1997)
Ryoji Tanaka:“唾液腺肿瘤的分子诊断和基因治疗” Int.J.Oral Maxillofac, Surg.. 26. 262 (1997)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
田中 良治: "Molecular Diagnesis and Gene Therapy of Salivary Gland Tumors"Int. J. Oral. Maxillofac. Surg.. 26. 262 (1997)
Ryoji Tanaka:“唾液腺肿瘤的分子诊断和基因治疗”Int. Oral Surg.. 26. 262 (1997)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
田中 良治: "Molecular diaguosis of human salivary glaud tumors by differential explession of fibiblast growth factor genes."Tissue. Culture Res. Commun.. 16. 207-212 (1997)
Ryoji Tanaka:“通过成纤维细胞生长因子基因的差异表达对人唾液腺肿瘤进行分子诊断。”组织培养通讯.. 16. 207-212 (1997)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
For growth factor-receptor system molecules target, a development study of genetic diagnosis and treatment in oral & maxilla-facial disease
  • 批准号:
    16592001
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.3万
  • 财政年份:
    2004
  • 负责人:
    TANAKA Yoshiharu
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
  • 批准号:
    31970691
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2019
  • 负责人:
    张胜萍
  • 依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
  • 批准号:
    31900527
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2019
  • 负责人:
    孙磊
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位: